Niche-dependent gene expression profile of intratumoral heterogeneous ovarian cancer stem cell populations

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Abelson, Sagi ^a   Shamai, Yeela ^a   Berger, Liron ^a   Skorecki, Karl ^a,b   Tzukerman, Maty ^b  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b RAMBAM MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE DEHYDROGENASE; HERMES ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER STEM CELL; CELL RENEWAL; CLEAR CELL CARCINOMA; CONTROLLED STUDY; EMBRYONIC STEM CELL; EPIGENETICS; GENE EXPRESSION; GENE ONTOLOGY; HEDGEHOG SIGNALING PATHWAY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NOTCH SIGNALING PATHWAY; OVARY CANCER; PHENOTYPIC VARIATION; SIGNAL TRANSDUCTION; STEM CELL NICHE; TUMOR DIFFERENTIATION; TUMOR GROWTH; TUMOR MICROENVIRONMENT; WNT SIGNALING PATHWAY;

ADENOCARCINOMA, CLEAR CELL; ANIMALS; CELLS, CULTURED; FEMALE; HUMANS; MICE; MICE, SCID; MICROARRAY ANALYSIS; MIDDLE AGED; NEOPLASTIC STEM CELLS; OVARIAN NEOPLASMS; STEM CELL NICHE; TRANSCRIPTOME;

EID: 84892946853     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0083651     Document Type: Article

References (64)

1. Kreso A, O'Brien CA, van Galen P, Gan OI, Notta F et al. (2013) Variable clonal repopulation dynamics influence chemotherapy response in colorectal cancer. Science 339: 543-548. doi:10.1126/science.1227670. PubMed: 23239622.
2. Marusyk A, Polyak K (2010) Tumor heterogeneity: causes and consequences. Biochim Biophys Acta 1805: 105-117. PubMed: 19931353.
3. Polyak K, Haviv I, Campbell IG (2009) Co-evolution of tumor cells and their microenvironment. Trends Genet 25: 30-38. doi:10.1016/j.tig. 2008.10.012. PubMed: 19054589.
4. Shackleton M, Quintana E, Fearon ER, Morrison SJ (2009) Heterogeneity in cancer: cancer stem cells versus clonal evolution. Cell 138: 822-829. doi:10.1016/j.cell.2009.08.017. PubMed: 19737509.
5. Abelson S, Shamai Y, Berger L, Shouval R, Skorecki K et al. (2012) Intratumoral heterogeneity in the self-renewal and tumorigenic differentiation of ovarian cancer. Stem Cells 30: 415-424. doi:10.1002/stem.1029. PubMed: 22267284.
6. Gerlinger M, Rowan AJ, Horswell S, Larkin J, Endesfelder D et al. (2012) Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med 366: 883-892. doi:10.1056/NEJMoa1113205. PubMed: 22397650.
7. Yap TA, Gerlinger M, Futreal PA, Pusztai L, Swanton C (2012) Intratumor heterogeneity: seeing the wood for the trees. Sci Transl Med 4: 127ps110. PubMed: 22461637.
8. Gupta PB, Chaffer CL, Weinberg RA (2009) Cancer stem cells: mirage or reality? Nat Med 15: 1010-1012. doi:10.1038/nm0909-1010. PubMed: 19734877.
9. Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144: 646-674. doi:10.1016/j.cell.2011.02.013. PubMed: 21376230.
10. Scheel C, Weinberg RA (2012) Cancer stem cells and epithelial-mesenchymal transition: concepts and molecular links. Semin Cancer Biol 22: 396-403. doi:10.1016/j.semcancer.2012.04.001. PubMed: 22554795.
11. van der Horst G, Bos L, van der Pluijm G (2012) Epithelial plasticity, cancer stem cells, and the tumor-supportive stroma in bladder carcinoma. Mol Cancer Res 10: 995-1009. doi: 10.1158/1541-7786.MCR-12-0274. PubMed: 22714124.
12. Berry NB, Bapat SA (2008) Ovarian cancer plasticity and epigenomics in the acquisition of a stem-like phenotype. J Ovarian Res 1: 8. doi: 10.1186/1757-2215-1-8. PubMed: 19025622.
13. Ebben JD, Treisman DM, Zorniak M, Kutty RG, Clark PA et al. (2010) The cancer stem cell paradigm: a new understanding of tumor development and treatment. Expert Opin Ther Targets 14: 621-632. doi:10.1517/14712598.2010. 485186. PubMed: 20426697.
14. Borovski T, De Sousa EMF, Vermeulen L, Medema JP (2011) Cancer stem cell niche: the place to be. Cancer Res 71: 634-639. doi: 10.1158/0008-5472.CAN-10- 3220. PubMed: 21266356.
15. Chaffer CL, Brueckmann I, Scheel C, Kaestli AJ, Wiggins PA et al. (2011) Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state. Proc Natl Acad Sci U S A 108: 7950-7955. doi: 10.1073/pnas.1102454108. PubMed: 21498687.
16. Clevers H (2011) The cancer stem cell: premises, promises and challenges. Nat Med 17: 313-319. PubMed: 21386835.
17. Bergfeld SA, DeClerck YA (2010) Bone marrow-derived mesenchymal stem cells and the tumor microenvironment. Cancer Metastasis Rev 29: 249-261. doi:10.1007/s10555-010-9222-7. PubMed: 20411303.
18. Nishimura K, Semba S, Aoyagi K, Sasaki H, Yokozaki H (2012) Mesenchymal stem cells provide an advantageous tumor microenvironment for the restoration of cancer stem cells. Pathobiology 79: 290-306. doi:10.1159/000337296. PubMed: 22688186.
19. Folkman J (2004) A novel anti-vascular therapy for cancer. Cancer Biol Ther 3: 338-339. doi:10.4161/cbt.3.3.708. PubMed: 14726666.
20. de Visser KE, Korets LV, Coussens LM (2005) De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent. Cancer Cell 7: 411-423. doi:10.1016/j.ccr.2005.04.014. PubMed: 15894262.
21. Kuperwasser C, Chavarria T, Wu M, Magrane G, Gray JW et al. (2004) Reconstruction of functionally normal and malignant human breast tissues in mice. Proc Natl Acad Sci U S A 101: 4966-4971. doi:10.1073/pnas.0401064101. PubMed: 15051869.
22. Orimo A, Weinberg RA (2006) Stromal fibroblasts in cancer: a novel tumor-promoting cell type. Cell Cycle 5: 1597-1601. doi:10.4161/cc. 5.15.3112. PubMed: 16880743.
23. Kalluri R, Zeisberg M (2006) Fibroblasts in cancer. Nat Rev Cancer 6: 392-401. doi:10.1038/nrc1877. PubMed: 16572188.
24. Sung SY, Hsieh CL, Wu D, Chung LW, Johnstone PA (2007) Tumor microenvironment promotes cancer progression, metastasis, and therapeutic resistance. Curr Probl Cancer 31: 36-100. doi:10.1016/j.currproblcancer.2006.12. 002. PubMed: 17362788.
25. Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100: 57-70. doi:10.1016/S0092-8674(00)81683-9. PubMed: 10647931.
26. Rosen JM, Jordan CT (2009) The increasing complexity of the cancer stem cell paradigm. Science 324: 1670-1673. doi:10.1126/science. 1171837. PubMed: 19556499.
27. Bissell MJ, Labarge MA (2005) Context, tissue plasticity, and cancer: are tumor stem cells also regulated by the microenvironment? Cancer Cell 7: 17-23. doi:10.1016/j.ccr.2004.12.013. PubMed: 15652746.
28. Greaves M, Maley CC (2012) Clonal evolution in cancer. Nature 481: 306-313. doi:10.1038/nature10762. PubMed: 22258609.
29. Tzukerman M, Rosenberg T, Ravel Y, Reiter I, Coleman R et al. (2003) An experimental platform for studying growth and invasiveness of tumor cells within teratomas derived from human embryonic stem cells. Proc Natl Acad Sci U S A 100: 13507-13512. doi:10.1073/pnas. 2235551100. PubMed: 14573705.
30. Tzukerman M, Rosenberg T, Reiter I, Ben-Eliezer S, Denkberg G et al. (2006) The influence of a human embryonic stem cell-derived microenvironment on targeting of human solid tumor xenografts. Cancer Res 66: 3792-3801. doi:10.1158/0008-5472.CAN-05-3467. PubMed: 16585206.
31. Czernobilsky B, Silverman BB, Enterline HT (1970) Clear-cell carcinoma of the ovary. A clinicopathologic analysis of pure and mixed forms and comparison with endometrioid carcinoma. Cancer 25: 762-772. doi:10.1002/1097-0142(197004) 25:4. PubMed: 5443100.
32. Montag AG, Jenison EL, Griffiths CT, Welch WR, Lavin PT et al. (1989) Ovarian clear cell carcinoma. A clinicopathologic analysis of 44 cases. Int J Gynecol Pathol 8: 85-96. doi: 10.1097/00004347-198906000-00001. PubMed: 2469661.
33. Tan DS, Kaye S (2007) Ovarian clear cell adenocarcinoma: a continuing enigma. J Clin Pathol 60: 355-360. PubMed: 17018684.
34. Köbel M, Kalloger SE, Carrick J, Huntsman D, Asad H et al. (2009) A limited panel of immunomarkers can reliably distinguish between clear cell and high-grade serous carcinoma of the ovary. Am J Surg Pathol 33: 14-21. doi:10.1097/PAS.0b013e3181788546. PubMed: 18830127.
35. DeLair D, Oliva E, Köbel M, Macias A, Gilks CB et al. (2011) Morphologic spectrum of immunohistochemically characterized clear cell carcinoma of the ovary: a study of 155 cases. Am J Surg Pathol 35: 36-44. doi:10.1097/PAS.0b013e3181ff400e. PubMed: 21164285.
36. Katz E, Skorecki K, Tzukerman M (2009) Niche-dependent tumorigenic capacity of malignant ovarian ascites-derived cancer cell subpopulations. Clin Cancer Res 15: 70-80. doi: 10.1158/1078-0432.CCR-08-1233. PubMed: 19118034.
37. Burgos-Ojeda D, McLean K, Bai S, Pulaski H, Gong Y et al. (2013) A novel model for evaluating therapies targeting human tumor vasculature and human cancer stem-like cells. Cancer Res 73: 3555-3565. doi:10.1158/0008-5472.CAN-12- 2845. PubMed: 23576551.
38. Kubota T, Nonoyama S, Tonoki H, Masuno M, Imaizumi K et al. (1999) A new assay for the analysis of X-chromosome inactivation based on methylation-specific PCR. Hum Genet 104: 49-55. doi:10.1007/s004390050909. PubMed: 10071192.
39. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL et al. (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102: 15545-15550. doi:10.1073/pnas.0506580102. PubMed: 16199517.
40. Eden E, Navon R, Steinfeld I, Lipson D, Yakhini Z (2009) GOrilla: a tool for discovery and visualization of enriched GO terms in ranked gene lists. BMC Bioinformatics 10: 48. doi:10.1186/1471-2105-10-48. PubMed: 19192299.
41. Espada J, Calvo MB, Díaz-Prado S, Medina V (2009) Wnt signalling and cancer stem cells. Clin Transl Oncol 11: 411-427. doi:10.1007/s12094-009- 0380-4. PubMed: 19574199.
42. Wang Z, Li Y, Banerjee S, Sarkar FH (2009) Emerging role of Notch in stem cells and cancer. Cancer Lett 279: 8-12. doi:10.1016/j.canlet. 2008.09.030. PubMed: 19022563.
43. Medina V, Calvo MB, Díaz-Prado S, Espada J (2009) Hedgehog signalling as a target in cancer stem cells. Clin Transl Oncol 11: 199-207. doi:10.1007/s12094-009-0341-y. PubMed: 19380296.
44. Schmid R, Baum P, Ittrich C, Fundel-Clemens K, Huber W et al. (2010) Comparison of normalization methods for Illumina BeadChip HumanHT-12 v3. BMC Genomics 11: 349. doi: 10.1186/1471-2164-11-349. PubMed: 20525181.
45. Young LC, Campling BG, Cole SP, Deeley RG, Gerlach JH (2001) Multidrug resistance proteins MRP3, MRP1, and MRP2 in lung cancer: correlation of protein levels with drug response and messenger RNA levels. Clin Cancer Res 7: 1798-1804. PubMed: 11410522.
46. Lucci A, Cho WI, Han TY, Giuliano AE, Morton DL et al. (1998) Glucosylceramide: a marker for multiple-drug resistant cancers. Anticancer Res 18: 475-480. PubMed: 9568165.
47. Rodriguez-Antona C, Ingelman-Sundberg M (2006) Cytochrome P450 pharmacogenetics and cancer. Oncogene 25: 1679-1691. doi:10.1038/sj.onc.1209377. PubMed: 16550168.
48. You A, Fokas E, Wang LF, He H, Kleb B et al. (2011) Expression of the Wnt antagonist DKK3 is frequently suppressed in sporadic epithelial ovarian cancer. J Cancer Res Clin Oncol 137: 621-627. doi:10.1007/s00432-010-0916-6. PubMed: 20532910.
49. Ginestier C, Hur MH, Charafe-Jauffret E, Monville F, Dutcher J et al. (2007) ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 1: 555-567. doi:10.1016/j.stem.2007.08.014. PubMed: 18371393.
50. Goldstein AS, Lawson DA, Cheng D, Sun W, Garraway IP et al. (2008) Trop2 identifies a subpopulation of murine and human prostate basal cells with stem cell characteristics. Proc Natl Acad Sci U S A 105: 20882-20887. doi:10.1073/pnas.0811411106. PubMed: 19088204.
51. Yu YP, Yu G, Tseng G, Cieply K, Nelson J et al. (2007) Glutathione peroxidase 3, deleted or methylated in prostate cancer, suppresses prostate cancer growth and metastasis. Cancer Res 67: 8043-8050. doi:10.1158/0008-5472. CAN-07-0648. PubMed: 17804715.
52. Ringel MD, Hardy E, Bernet VJ, Burch HB, Schuppert F et al. (2002) Metastin receptor is overexpressed in papillary thyroid cancer and activates MAP kinase in thyroid cancer cells. J Clin Endocrinol Metab 87: 2399. doi:10.1210/jc.87.5.2399. PubMed: 11994395.
53. Mibayashi M, Nakad K, Nagata K (2002) Promoted cell death of cells expressing human MxA by influenza virus infection. Microbiol Immunol 46: 29-36. doi:10.1111/j.1348-0421.2002.tb02673.x. PubMed: 11911186.
54. Yang J, Bielenberg DR, Rodig SJ, Doiron R, Clifton MC et al. (2009) Lipocalin 2 promotes breast cancer progression. Proc Natl Acad Sci U S A 106: 3913-3918. doi:10.1073/pnas.0810617106. PubMed: 19237579.
55. van Vlerken LE, Hurt EM, Hollingsworth RE (2012) The role of epigenetic regulation in stem cell and cancer biology. J Mol Med (Berl) 90: 791-801. doi:10.1007/s00109-012-0917-9. PubMed: 22660276.
56. Vincent A, Van Seuningen I (2012) On the epigenetic origin of cancer stem cells. Biochim Biophys Acta 1826: 83-88. PubMed: 22495062.
57. He Y, Wang Y, Li P, Zhu S, Wang J et al. (2011) Identification of GPX3 epigenetically silenced by CpG methylation in human esophageal squamous cell carcinoma. Dig Dis Sci 56: 681-688. doi:10.1007/s10620-010-1369-0. PubMed: 20725785.
58. Calmon MF, Rodrigues RV, Kaneto CM, Moura RP, Silva SD et al. (2009) Epigenetic silencing of CRABP2 and MX1 in head and neck tumors. Neoplasia 11: 1329-1339. PubMed: 20019841.
59. Quintana E, Shackleton M, Sabel MS, Fullen DR, Johnson TM et al. (2008) Efficient tumour formation by single human melanoma cells. Nature 456: 593-598. doi:10.1038/nature07567. PubMed: 19052619.
60. Quintana E, Piskounova E, Shackleton M, Weinberg D, Eskiocak U et al. (2012) Human Melanoma Metastasis in NSG Mice Correlates with Clinical Outcome in Patients. Sci Transl Med 4: 159ra149. PubMed: 23136044.
61. Kajihara H, Yamada Y, Kanayama S, Furukawa N, Noguchi T et al. (2010) Clear cell carcinoma of the ovary: potential pathogenic mechanisms (Review). Oncol Rep 23: 1193-1203 PubMed: 20372830.
62. Schwartz DR, Kardia SL, Shedden KA, Kuick R, Michailidis G et al. (2002) Gene expression in ovarian cancer reflects both morphology and biological behavior, distinguishing clear cell from other poorprognosis ovarian carcinomas. Cancer Res 62: 4722-4729. PubMed: 12183431.
63. Zorn KK, Bonome T, Gangi L, Chandramouli GV, Awtrey CS et al. (2005) Gene expression profiles of serous, endometrioid, and clear cell subtypes of ovarian and endometrial cancer. Clin Cancer Res 11: 6422-6430. doi:10.1158/1078-0432. CCR-05-0508. PubMed: 16166416.
64. Jamil S, Cedervall J, Hultman I, Ali R, Margaryan NV et al. (2013) Neuroblastoma cells injected into experimental mature teratoma reveal a tropism for embryonic loose mesenchyme. Int J Oncol 43: 831-838. PubMed: 23857308.